ZetaRx Biosciences, Inc. — Form D/A
ZetaRx Biosciences, Inc. of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2013-08-23. The offering totals $12.0M, of which $2.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-08-23
- Form: D/A
- Accession: 0001508561-13-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $12.0M
- Amount sold: $2.0M
- Remaining: $10.0M
- Investors: 4
- Date of first sale: 2012-11-30
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-188260
Issuer
- Name: ZetaRx Biosciences, Inc.
- CIK: 0001508561
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 1601 5TH AVENUE, SUITE 2060, SEATTLE, WA, 98101
- Phone: 206 262-5696
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| David A Dull | Director | Carlsbad, CA |
| D. Verne Sharma | Director | Pasadena, CA |
| Robert Verne Snukal | Director | Sunny Isles Beach, FL |
| Werner F Wolfen | Director | Pasadena, CA |
| Ken A Mohler | Executive Officer | Seattle, WA |
| Cynthia Shumate | Executive Officer | Seattle, WA |
| Werner F Wolfen | Executive Officer | Pasadena, CA |
| Jack Kavanaugh | Director | SAN DIEGO, CA |
| Jack Kavanaugh | Executive Officer | SAN DIEGO, CA |
| Gordon M Binder | Director | Pasadena, CA |
| Gordon M Binder | Executive Officer | Pasadena, CA |
| Cynthia M Shumate | Executive Officer | Seattle, WA |
| Edmund M Olivier | Director | Malibu, CA |
| Cynthia Verne Shumate | Executive Officer | Seattle, WA |
| Robert F Snukal | Director | Santa Monica, CA |
Other filings by this issuer (2)
More